Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Renovaro Biosciences ( (RENB) ) has shared an announcement.
Renovaro Inc. received a notice from Nasdaq on July 7, 2025, for failing to comply with the requirement to hold an annual meeting of shareholders within a year after the fiscal year ended June 30, 2024. The company has 45 days to submit a compliance plan, and if accepted, could receive an extension until December 29, 2025. While the notice does not immediately affect the company’s stock listing, failure to comply may lead to delisting.
More about Renovaro Biosciences
Average Trading Volume: 3,550,025
Technical Sentiment Signal: Sell
Current Market Cap: $46.47M
Learn more about RENB stock on TipRanks’ Stock Analysis page.